2024 Q2 Form 10-Q Financial Statement

#000164763924000022 Filed on May 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $127.6M $127.8M
YoY Change -5.99% 24.16%
Cost Of Revenue $38.68M $39.41M
YoY Change 5.12% -2.91%
Gross Profit $88.95M $88.39M
YoY Change -16.8% 15.46%
Gross Profit Margin 69.69% 69.16%
Selling, General & Admin $85.98M $92.76M
YoY Change 15.66% 10.3%
% of Gross Profit 96.66% 104.95%
Research & Development $58.45M $63.09M
YoY Change 0.83% -42.68%
% of Gross Profit 65.72% 71.38%
Depreciation & Amortization $4.500M $5.632M
YoY Change 2.27% -12.56%
% of Gross Profit 5.06% 6.37%
Operating Expenses $183.1M $195.3M
YoY Change 8.28% -16.83%
Operating Profit -$55.49M -$67.47M
YoY Change 66.4% -48.82%
Interest Expense $10.71M
YoY Change 50.22%
% of Operating Profit
Other Income/Expense, Net $1.031M $2.884M
YoY Change -80.16% 11.05%
Pretax Income -$54.46M -$64.58M
YoY Change 93.79% -50.03%
Income Tax $15.00K $14.00K
% Of Pretax Income
Net Earnings -$54.47M -$64.60M
YoY Change 93.4% -50.02%
Net Earnings / Revenue -42.68% -50.55%
Basic Earnings Per Share -$0.62 -$0.74
Diluted Earnings Per Share -$0.62 -$0.74
COMMON SHARES
Basic Shares Outstanding 87.88M shares 86.43M shares
Diluted Shares Outstanding 88.44M shares 87.03M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $374.8M $300.5M
YoY Change -15.53% -22.33%
Cash & Equivalents $560.6M $439.2M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $414.8M $341.2M
YoY Change -15.31% -20.64%
LONG-TERM ASSETS
Property, Plant & Equipment $39.73M $40.56M
YoY Change -15.49% -13.67%
Goodwill $67.10M $67.10M
YoY Change 0.0% 0.0%
Intangibles $10.00M $10.29M
YoY Change -25.87% -29.36%
Long-Term Investments $41.25M $41.25M
YoY Change -0.12% 0.0%
Other Assets $204.0M $161.6M
YoY Change 143.4% 85.89%
Total Long-Term Assets $1.405B $1.587B
YoY Change 10.32% 13.99%
TOTAL ASSETS
Total Short-Term Assets $414.8M $341.2M
Total Long-Term Assets $1.405B $1.587B
Total Assets $1.820B $1.928B
YoY Change 3.2% 5.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $79.38M $69.10M
YoY Change 55.65% 45.16%
Accrued Expenses $100.0M $94.76M
YoY Change -25.12% -27.92%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $293.1M $293.0M
YoY Change 58.76% 63.59%
LONG-TERM LIABILITIES
Long-Term Debt $912.7M $1.005B
YoY Change -1.93% 0.44%
Other Long-Term Liabilities $19.72M $16.64M
YoY Change 89.58% 14.22%
Total Long-Term Liabilities $932.4M $1.022B
YoY Change -0.92% 0.64%
TOTAL LIABILITIES
Total Short-Term Liabilities $293.1M $293.0M
Total Long-Term Liabilities $932.4M $1.022B
Total Liabilities $1.226B $1.315B
YoY Change 8.88% 10.08%
SHAREHOLDERS EQUITY
Retained Earnings -$401.6M -$347.2M
YoY Change 100.96% 102.2%
Common Stock $9.000K $9.000K
YoY Change 12.5% 12.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $594.7M $612.8M
YoY Change
Total Liabilities & Shareholders Equity $1.820B $1.928B
YoY Change 3.2% 5.82%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$54.47M -$64.60M
YoY Change 93.4% -50.02%
Depreciation, Depletion And Amortization $4.500M $5.632M
YoY Change 2.27% -12.56%
Cash From Operating Activities $65.30M $52.62M
YoY Change -59.79% -169.49%
INVESTING ACTIVITIES
Capital Expenditures $2.328M $684.0K
YoY Change 16.4% -38.43%
Acquisitions
YoY Change
Other Investing Activities -$73.77M -$35.80M
YoY Change 102.12% 75.53%
Cash From Investing Activities -$76.10M -$37.55M
YoY Change 98.18% 45.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 132.3M -$43.71M
YoY Change -300.72% -308.44%
NET CHANGE
Cash From Operating Activities 65.30M $52.62M
Cash From Investing Activities -76.10M -$37.55M
Cash From Financing Activities 132.3M -$43.71M
Net Change In Cash 121.5M -$28.64M
YoY Change 109.07% -64.47%
FREE CASH FLOW
Cash From Operating Activities $65.30M $52.62M
Capital Expenditures $2.328M $684.0K
Free Cash Flow $62.97M $51.94M
YoY Change -60.74% -167.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Interest Expense
InterestExpense
7132000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
10714000 usd
CY2023Q1 upst Fair Value And Other Adjustments Net
FairValueAndOtherAdjustmentsNet
52397000 usd
CY2024Q1 upst Fair Value And Other Adjustments Net
FairValueAndOtherAdjustmentsNet
50731000 usd
CY2023Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
1100000 usd
CY2024Q1 us-gaap Deposits Assets
DepositsAssets
6439000 usd
CY2024Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
62055000 usd
CY2023Q4 upst Long Term And Short Term Debt Gross
LongTermAndShortTermDebtGross
1048675000 usd
CY2024Q1 upst Long Term And Short Term Debt Gross
LongTermAndShortTermDebtGross
1012760000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
8251000 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
7483000 usd
CY2023Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1040424000 usd
CY2024Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1005277000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
9100000 usd
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
7900000 usd
CY2024Q1 us-gaap Financing Receivable Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List
FinancingReceivableAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#NotesReceivableNet
CY2023Q4 us-gaap Financing Receivable Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List
FinancingReceivableAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#NotesReceivableNet
CY2023Q1 us-gaap Interest Income Operating
InterestIncomeOperating
45315000 usd
CY2024Q1 us-gaap Interest Income Operating
InterestIncomeOperating
51171000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-14214000 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-10274000 usd
CY2023Q1 us-gaap Revenues
Revenues
102927000 usd
CY2024Q1 us-gaap Revenues
Revenues
127794000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
31438000 usd
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
35150000 usd
CY2023Q1 upst Customer Operations Expense
CustomerOperationsExpense
40590000 usd
CY2024Q1 upst Customer Operations Expense
CustomerOperationsExpense
39408000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
110071000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
63091000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
52663000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
57613000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
234762000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
195262000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-131835000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-67468000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2597000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2884000 usd
CY2023Q1 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-129238000 usd
CY2024Q1 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-64584000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-129254000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-64598000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.58
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.74
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.58
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.74
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81911433 shares
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
87030695 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81911433 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
87030695 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
672435000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1537000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
5000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
76767000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
5728000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-129254000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
627208000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
635305000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1204000 usd
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
36323000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
4565000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-64598000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
612798000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-129254000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-64598000 usd
CY2023Q1 us-gaap Increase Decrease In Finance Receivables
IncreaseDecreaseInFinanceReceivables
-54924000 usd
CY2024Q1 us-gaap Increase Decrease In Finance Receivables
IncreaseDecreaseInFinanceReceivables
-54017000 usd
CY2023Q1 upst Increase Decrease In Fair Value Of Servicing Assets
IncreaseDecreaseInFairValueOfServicingAssets
-5479000 usd
CY2024Q1 upst Increase Decrease In Fair Value Of Servicing Assets
IncreaseDecreaseInFairValueOfServicingAssets
-4286000 usd
CY2023Q1 upst Increase Decrease In Fair Value Of Servicing Liabilities
IncreaseDecreaseInFairValueOfServicingLiabilities
-875000 usd
CY2024Q1 upst Increase Decrease In Fair Value Of Servicing Liabilities
IncreaseDecreaseInFairValueOfServicingLiabilities
-454000 usd
CY2023Q1 upst Increase Decrease In Fair Value Of Beneficial Interest Assets
IncreaseDecreaseInFairValueOfBeneficialInterestAssets
0 usd
CY2024Q1 upst Increase Decrease In Fair Value Of Beneficial Interest Assets
IncreaseDecreaseInFairValueOfBeneficialInterestAssets
4481000 usd
CY2023Q1 upst Increase Decrease In Fair Value Of Beneficial Interest Liabilities
IncreaseDecreaseInFairValueOfBeneficialInterestLiabilities
0 usd
CY2024Q1 upst Increase Decrease In Fair Value Of Beneficial Interest Liabilities
IncreaseDecreaseInFairValueOfBeneficialInterestLiabilities
4973000 usd
CY2023Q1 us-gaap Increase Decrease In Other Financial Instruments Used In Operating Activities
IncreaseDecreaseInOtherFinancialInstrumentsUsedInOperatingActivities
482000 usd
CY2024Q1 us-gaap Increase Decrease In Other Financial Instruments Used In Operating Activities
IncreaseDecreaseInOtherFinancialInstrumentsUsedInOperatingActivities
-1551000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
74109000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
35777000 usd
CY2023Q1 upst Gain Loss On Loan Servicing Rights And Sale Of Noncontrolling Interests Net
GainLossOnLoanServicingRightsAndSaleOfNoncontrollingInterestsNet
3613000 usd
CY2024Q1 upst Gain Loss On Loan Servicing Rights And Sale Of Noncontrolling Interests Net
GainLossOnLoanServicingRightsAndSaleOfNoncontrollingInterestsNet
2946000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6441000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5632000 usd
CY2023Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
766000 usd
CY2024Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
768000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
974000 usd
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
2539000 usd
CY2023Q1 us-gaap Payments To Purchase Loans Held For Sale
PaymentsToPurchaseLoansHeldForSale
510003000 usd
CY2024Q1 us-gaap Payments To Purchase Loans Held For Sale
PaymentsToPurchaseLoansHeldForSale
796543000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
449339000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
772690000 usd
CY2023Q1 us-gaap Proceeds From Collection Of Loans Held For Sale
ProceedsFromCollectionOfLoansHeldForSale
57949000 usd
CY2024Q1 us-gaap Proceeds From Collection Of Loans Held For Sale
ProceedsFromCollectionOfLoansHeldForSale
52841000 usd
CY2023Q1 us-gaap Proceeds From Securitizations Of Loans Held For Sale
ProceedsFromSecuritizationsOfLoansHeldForSale
0 usd
CY2024Q1 us-gaap Proceeds From Securitizations Of Loans Held For Sale
ProceedsFromSecuritizationsOfLoansHeldForSale
12338000 usd
CY2023Q1 upst Payments On Beneficial Interest Liabilities
PaymentsOnBeneficialInterestLiabilities
0 usd
CY2024Q1 upst Payments On Beneficial Interest Liabilities
PaymentsOnBeneficialInterestLiabilities
710000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-306000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
825000 usd
CY2023Q1 upst Increase Decrease In Operating Lease Liability And Right Of Use Asset
IncreaseDecreaseInOperatingLeaseLiabilityAndRightOfUseAsset
1216000 usd
CY2024Q1 upst Increase Decrease In Operating Lease Liability And Right Of Use Asset
IncreaseDecreaseInOperatingLeaseLiabilityAndRightOfUseAsset
-202000 usd
CY2023Q1 upst Increase Decrease In Payable To Investors
IncreaseDecreaseInPayableToInvestors
-49730000 usd
CY2024Q1 upst Increase Decrease In Payable To Investors
IncreaseDecreaseInPayableToInvestors
6893000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-31325000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-25846000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-75727000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
52622000 usd
CY2023Q1 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
46382000 usd
CY2024Q1 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
46152000 usd
CY2023Q1 us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
24422000 usd
CY2024Q1 us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
27242000 usd
CY2023Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
1566000 usd
CY2024Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
1225000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1111000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
684000 usd
CY2023Q1 us-gaap Payments For Software
PaymentsForSoftware
4347000 usd
CY2024Q1 us-gaap Payments For Software
PaymentsForSoftware
1065000 usd
CY2023Q1 upst Acquisition Of Beneficial Interest Assets
AcquisitionOfBeneficialInterestAssets
0 usd
CY2024Q1 upst Acquisition Of Beneficial Interest Assets
AcquisitionOfBeneficialInterestAssets
16940000 usd
CY2023Q1 upst Payments On Beneficial Interest Assets
PaymentsOnBeneficialInterestAssets
0 usd
CY2024Q1 upst Payments On Beneficial Interest Assets
PaymentsOnBeneficialInterestAssets
1173000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25852000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-37547000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
60673000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
74260000 usd
CY2023Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
46962000 usd
CY2024Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
110175000 usd
CY2023Q1 us-gaap Repayments Of Accounts Receivable Securitization
RepaymentsOfAccountsReceivableSecuritization
0 usd
CY2024Q1 us-gaap Repayments Of Accounts Receivable Securitization
RepaymentsOfAccountsReceivableSecuritization
13564000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
5728000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
4565000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1537000 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1204000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5000 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20971000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-43711000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-80608000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-28636000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
532467000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
467787000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
451859000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
439151000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
7959000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
12463000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-1153000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
88000 usd
CY2023Q1 upst Beneficial Interests Obtained In Connection With Loan Sale
BeneficialInterestsObtainedInConnectionWithLoanSale
0 usd
CY2024Q1 upst Beneficial Interests Obtained In Connection With Loan Sale
BeneficialInterestsObtainedInConnectionWithLoanSale
13555000 usd
CY2024Q1 upst Unrealized Gain Loss Charge Offs And Other Fair Value Adjustments Net
UnrealizedGainLossChargeOffsAndOtherFairValueAdjustmentsNet
-29593000 usd
CY2023Q1 upst Issuance Of Beneficial Interests
IssuanceOfBeneficialInterests
0 usd
CY2024Q1 upst Issuance Of Beneficial Interests
IssuanceOfBeneficialInterests
4400000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
2658000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
546000 usd
CY2023Q4 us-gaap Cash
Cash
368405000 usd
CY2024Q1 us-gaap Cash
Cash
300529000 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
99382000 usd
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
138622000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
467787000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
439151000 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires that management make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant estimates and assumptions made in the accompanying condensed consolidated financial statements, which Management believes are critical in understanding and evaluating the Company’s reported financial results include: (i) fair value determinations; (ii) stock-based compensation; (iii) consolidation of VIEs; and (iv) the evaluation for impairment of goodwill. The Company bases its estimates on various factors it believes to be reasonable under the circumstances. Actual results could differ from those estimates and such differences could affect the results of operations reported in future periods.</span></div>
CY2023Q1 upst Realized Gain Loss On Transfer Of Loans Net
RealizedGainLossOnTransferOfLoansNet
-7853000 usd
CY2024Q1 upst Realized Gain Loss On Transfer Of Loans Net
RealizedGainLossOnTransferOfLoansNet
-7104000 usd
CY2023Q1 upst Gain Loss On Beneficial Interests
GainLossOnBeneficialInterests
0 usd
CY2024Q1 upst Gain Loss On Beneficial Interests
GainLossOnBeneficialInterests
-14034000 usd
CY2023Q1 upst Fair Value And Other Adjustments Net
FairValueAndOtherAdjustmentsNet
52397000 usd
CY2024Q1 upst Fair Value And Other Adjustments Net
FairValueAndOtherAdjustmentsNet
50731000 usd
CY2023Q1 upst Interest Income And Fair Value Adjustment Net
InterestIncomeAndFairValueAdjustmentNet
-14214000 usd
CY2024Q1 upst Interest Income And Fair Value Adjustment Net
InterestIncomeAndFairValueAdjustmentNet
-10274000 usd
CY2024Q1 us-gaap Financing Receivable Threshold Period Past Due
FinancingReceivableThresholdPeriodPastDue
P120D
CY2023Q4 us-gaap Financing Receivable Accrued Interest After Allowance For Credit Loss
FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss
14200000 usd
CY2023Q1 upst Revenue From Fees Net
RevenueFromFeesNet
117141000 usd
CY2024Q1 upst Revenue From Fees Net
RevenueFromFeesNet
138068000 usd
CY2023Q4 upst Trailing Fee Liabilities Fair Value Disclosure
TrailingFeeLiabilitiesFairValueDisclosure
4300000 usd
CY2024Q1 upst Trailing Fee Liabilities Fair Value Disclosure
TrailingFeeLiabilitiesFairValueDisclosure
4200000 usd
CY2023Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
2700000 usd
CY2024Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
2400000 usd
CY2023Q1 upst Gain Loss On Servicing Rights And Fair Value Adjustments
GainLossOnServicingRightsAndFairValueAdjustments
-990000 usd
CY2024Q1 upst Gain Loss On Servicing Rights And Fair Value Adjustments
GainLossOnServicingRightsAndFairValueAdjustments
-886000 usd
CY2023Q1 us-gaap Interest Income Operating
InterestIncomeOperating
45315000 usd
CY2024Q1 us-gaap Interest Income Operating
InterestIncomeOperating
51171000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
7132000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
10714000 usd
CY2023Q1 upst Unrealized Gain Loss Charge Offs And Other Fair Value Adjustments Net
UnrealizedGainLossChargeOffsAndOtherFairValueAdjustmentsNet
-44544000 usd
CY2024Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
1189158000 usd
CY2024Q1 us-gaap Financing Receivable Accrued Interest After Allowance For Credit Loss
FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss
12500000 usd
CY2023Q1 us-gaap Proceeds From Recoveries Of Loan Previously Charged Off
ProceedsFromRecoveriesOfLoanPreviouslyChargedOff
0 usd
CY2024Q1 us-gaap Proceeds From Recoveries Of Loan Previously Charged Off
ProceedsFromRecoveriesOfLoanPreviouslyChargedOff
3300000 usd
CY2024Q1 upst Variable Interest Entity Qualitative Or Quantitative Information Number Of Variable Interest Entity
VariableInterestEntityQualitativeOrQuantitativeInformationNumberOfVariableInterestEntity
2 variable_interest_entity
CY2023Q4 upst Beneficial Interests Maximum Loss Exposure
BeneficialInterestsMaximumLossExposure
98500000 usd
CY2024Q1 upst Beneficial Interests Maximum Loss Exposure
BeneficialInterestsMaximumLossExposure
169600000 usd
CY2023Q4 upst Beneficial Interest Asset Unpaid Principal Balance
BeneficialInterestAssetUnpaidPrincipalBalance
958870000 usd
CY2023Q4 upst Beneficial Interest Asset
BeneficialInterestAsset
41012000 usd
CY2024Q1 upst Beneficial Interest Asset Unpaid Principal Balance
BeneficialInterestAssetUnpaidPrincipalBalance
1468186000 usd
CY2024Q1 upst Beneficial Interest Asset
BeneficialInterestAsset
62214000 usd
CY2023Q4 upst Beneficial Interest Liability Unpaid Principal Balance
BeneficialInterestLiabilityUnpaidPrincipalBalance
769102000 usd
CY2023Q4 upst Beneficial Interest Liabilities
BeneficialInterestLiabilities
4221000 usd
CY2024Q1 upst Beneficial Interest Liability Unpaid Principal Balance
BeneficialInterestLiabilityUnpaidPrincipalBalance
873191000 usd
CY2024Q1 upst Beneficial Interest Liabilities
BeneficialInterestLiabilities
8485000 usd
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
1246322000 usd
CY2024Q1 us-gaap Financing Receivable Threshold Period Past Due
FinancingReceivableThresholdPeriodPastDue
P120D
CY2024Q1 us-gaap Financing Receivable Threshold Period Past Due Writeoff
FinancingReceivableThresholdPeriodPastDueWriteoff
P120D
CY2023Q4 upst Payable To Securitization Note Holders At Fair Value
PayableToSecuritizationNoteHoldersAtFairValue
141400000 usd
CY2024Q1 upst Payable To Securitization Note Holders At Fair Value
PayableToSecuritizationNoteHoldersAtFairValue
129100000 usd
CY2023Q4 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
28100000 usd
CY2024Q1 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
26800000 usd
CY2023Q4 us-gaap Servicing Liability At Fair Value Amount
ServicingLiabilityAtFairValueAmount
2000000 usd
CY2024Q1 us-gaap Servicing Liability At Fair Value Amount
ServicingLiabilityAtFairValueAmount
1600000 usd
CY2023Q4 upst Beneficial Interest Asset
BeneficialInterestAsset
41000000 usd
CY2024Q1 upst Beneficial Interest Asset
BeneficialInterestAsset
62200000 usd
CY2023Q4 upst Beneficial Interest Liabilities
BeneficialInterestLiabilities
4200000 usd
CY2024Q1 upst Beneficial Interest Liabilities
BeneficialInterestLiabilities
8500000 usd
CY2023Q4 upst Trailing Fee Liability At Fair Value Amount
TrailingFeeLiabilityAtFairValueAmount
4300000 usd
CY2024Q1 upst Trailing Fee Liability At Fair Value Amount
TrailingFeeLiabilityAtFairValueAmount
4200000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
67100000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
67100000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
23100000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
11756000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11344000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
23100000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
12825000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10275000 usd
CY2024Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
1100000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
856000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1142000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1142000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1142000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1142000 usd
CY2024Q1 upst Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
4851000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10275000 usd
CY2023Q4 us-gaap Accrued Fees And Other Revenue Receivable
AccruedFeesAndOtherRevenueReceivable
40490000 usd
CY2024Q1 us-gaap Accrued Fees And Other Revenue Receivable
AccruedFeesAndOtherRevenueReceivable
40624000 usd
CY2023Q4 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
28092000 usd
CY2024Q1 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
26753000 usd
CY2023Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
17976000 usd
CY2024Q1 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
23009000 usd
CY2023Q4 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
18589000 usd
CY2024Q1 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
18196000 usd
CY2023Q4 us-gaap Other Receivables
OtherReceivables
14847000 usd
CY2024Q1 us-gaap Other Receivables
OtherReceivables
13376000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
11356000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
10287000 usd
CY2023Q4 us-gaap Deposits Assets
DepositsAssets
8919000 usd
CY2023Q4 us-gaap Derivative Assets
DerivativeAssets
5958000 usd
CY2024Q1 us-gaap Derivative Assets
DerivativeAssets
5950000 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
146227000 usd
CY2024Q1 us-gaap Other Assets
OtherAssets
144634000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
80104000 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
82399000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
37449000 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
41844000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
42655000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
40555000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
5400000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
4600000 usd
CY2023Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
31300000 usd
CY2024Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
29700000 usd
CY2023Q1 us-gaap Capitalized Computer Software Impairments1
CapitalizedComputerSoftwareImpairments1
2600000 usd
CY2024Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2023Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
28099000 usd
CY2024Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
24609000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
30161000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
10790000 usd
CY2023Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
12613000 usd
CY2024Q1 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
10017000 usd
CY2023Q4 us-gaap Beneficial Interest
BeneficialInterest
4221000 usd
CY2024Q1 us-gaap Beneficial Interest
BeneficialInterest
8485000 usd
CY2023Q4 upst Trailing Fee Liability At Fair Value Amount
TrailingFeeLiabilityAtFairValueAmount
4251000 usd
CY2024Q1 upst Trailing Fee Liability At Fair Value Amount
TrailingFeeLiabilityAtFairValueAmount
4244000 usd
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
2668000 usd
CY2024Q1 us-gaap Other Liabilities
OtherLiabilities
2325000 usd
CY2023Q4 us-gaap Servicing Liability At Fair Value Amount
ServicingLiabilityAtFairValueAmount
2038000 usd
CY2024Q1 us-gaap Servicing Liability At Fair Value Amount
ServicingLiabilityAtFairValueAmount
1585000 usd
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
84051000 usd
CY2024Q1 upst Long Term And Short Term Debt Maturity Remainder Of Fiscal Year
LongTermAndShortTermDebtMaturityRemainderOfFiscalYear
0 usd
CY2024Q1 upst Long Term And Short Term Debt Maturity Year One
LongTermAndShortTermDebtMaturityYearOne
104382000 usd
CY2024Q1 upst Long Term And Short Term Debt Maturity Year Two
LongTermAndShortTermDebtMaturityYearTwo
908378000 usd
CY2024Q1 upst Long Term And Short Term Debt Maturity Year Three
LongTermAndShortTermDebtMaturityYearThree
0 usd
CY2024Q1 upst Long Term And Short Term Debt Maturity Year Four
LongTermAndShortTermDebtMaturityYearFour
0 usd
CY2024Q1 upst Long Term And Short Term Debt Maturity After Year Four
LongTermAndShortTermDebtMaturityAfterYearFour
0 usd
CY2024Q1 upst Long Term And Short Term Debt Gross
LongTermAndShortTermDebtGross
1012760000 usd
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000 shares
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
27468577 shares
CY2024Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
31173227 shares
CY2022Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
400000000 usd
CY2024Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
222100000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
12617254 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.57
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y1M6D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
375897000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1267617 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
25.76
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
351968 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.42
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
7570 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
12.75
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
13525333 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
15.91
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y3M18D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
200870000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
8895830 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
11.10
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y10M24D
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
169666000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
13492091 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
15.87
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y3M18D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
200807000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
4000000 usd
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
9500000 usd
CY2024Q1 upst Annual Target Bonus Opportunity Percentage Of Salary Percent
AnnualTargetBonusOpportunityPercentageOfSalaryPercent
0.75
CY2024Q1 upst Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Number Of Vesting Tranches
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfVestingTranches
9 vesting_tranche
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
74109000 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
35777000 usd
CY2024Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
3400000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
11231000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
15402000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
15850000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
15474000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
6143000 usd
CY2024Q1 upst Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
2990000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
67090000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
7726000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
59364000 usd
CY2023Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
0 usd
CY2024Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
0 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
4038000 usd
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
3542000 usd
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
976000 usd
CY2024Q1 us-gaap Variable Lease Cost
VariableLeaseCost
917000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
3665000 usd
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
3669000 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y3M25D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0513
CY2022Q2 us-gaap Loss Contingency New Claims Filed Number
LossContingencyNewClaimsFiledNumber
2 lawsuit
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0001
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0002
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-129254000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-64598000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81911433 shares
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
87030695 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81911433 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
87030695 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.58
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.74
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.58
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.74
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
24596844 shares
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
22304771 shares
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001647639-24-000022-index-headers.html Edgar Link pending
0001647639-24-000022-index.html Edgar Link pending
0001647639-24-000022.txt Edgar Link pending
0001647639-24-000022-xbrl.zip Edgar Link pending
exhibit311q12024.htm Edgar Link pending
exhibit312q12024.htm Edgar Link pending
exhibit321q12024.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
upst-20240331.htm Edgar Link pending
upst-20240331.xsd Edgar Link pending
upst-20240331_g1.jpg Edgar Link pending
upst-20240331_cal.xml Edgar Link unprocessable
upst-20240331_def.xml Edgar Link unprocessable
upst-20240331_lab.xml Edgar Link unprocessable
upst-20240331_pre.xml Edgar Link unprocessable
upst-20240331_htm.xml Edgar Link completed